Stock Scorer

Fresenius Medical Care AG (FMS)

Fresenius Medical Care AG reported revenue of 4.6B USD for the quarter ending 30 September 2016, up 9.5% from 4.2B a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q3 '16 · ending 30 September 2016 4.6B +9.5%
Gross Profit Q4 '16 · ending 31 December 2016 1.6B +8.4%
Operating Income Q4 '16 · ending 31 December 2016 786.2M +18.8%
Net Income Q4 '16 · ending 31 December 2016 388.1M +22.5%
Cost of Revenue Q4 '16 · ending 31 December 2016 3.1B +7.5%
Operating Cash Flow Q4 '16 · ending 31 December 2016 843.6M +53.8%
Free Cash Flow Q4 '16 · ending 31 December 2016 561.2M +131.2%
Shares Outstanding Q3 '25 · ending 30 September 2025 292.1M -0.4%
EPS Q1 '16 · ending 31 March 2016 3.44 -0.3%

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20142014-12-31 5.3B2.3B1B929.8M
20132013-12-31 5B2.3B1.1B1.3B

Every period

Revenue Quarterly

PeriodEndingRevenue
Q3 '162016-09-304.6B
Q2 '162016-06-304.4B
Q1 '162016-03-314.2B
Q3 '152015-09-304.2B
Q2 '152015-06-304.2B
Q3 '102010-09-303.1B
Q3 '092009-09-302.9B

Gross Profit Quarterly

PeriodEndingGross Profit
Q4 '162016-12-311.6B
Q3 '162016-09-301.5B
Q2 '162016-06-301.4B
Q1 '162016-03-311.3B
Q4 '152015-12-311.5B
Q3 '152015-09-301.4B
Q2 '152015-06-301.3B
Q1 '152015-03-311.2B
Q4 '142014-12-311.4B
Q3 '142014-09-301.3B
Q2 '142014-06-301.2B
Q1 '142014-03-311.1B
Q4 '132013-12-311.3B
Q3 '132013-09-301.2B
Q2 '132013-06-301.2B
Q1 '132013-03-311.1B
Q4 '122012-12-311.3B
Q3 '122012-09-301.1B
Q2 '122012-06-301.1B
Q1 '122012-03-311.1B

Operating Income Quarterly

PeriodEndingOperating Income
Q4 '162016-12-31786.2M
Q3 '162016-09-30669.9M
Q2 '162016-06-30641.1M
Q1 '162016-03-31540.3M
Q4 '152015-12-31661.8M
Q3 '152015-09-30613.5M
Q2 '152015-06-30547M
Q1 '152015-03-31504.4M
Q4 '142014-12-31663.4M
Q3 '142014-09-30589.9M
Q2 '142014-06-30556.3M
Q1 '142014-03-31444.9M
Q4 '132013-12-31661.4M
Q3 '132013-09-30557.3M
Q2 '132013-06-30544.2M
Q1 '132013-03-31493.3M
Q4 '122012-12-31559.1M
Q3 '122012-09-30567.6M
Q2 '122012-06-30588.8M
Q1 '122012-03-31503M

Net Income Quarterly

PeriodEndingNet Income
Q4 '162016-12-31388.1M
Q3 '162016-09-30333.2M
Q2 '162016-06-30293.9M
Q1 '162016-03-31228M
Q4 '152015-12-31316.8M
Q3 '152015-09-30262.3M
Q2 '152015-06-30240.8M
Q1 '152015-03-31209.5M
Q4 '142014-12-31335.3M
Q3 '142014-09-30270.8M
Q2 '142014-06-30233.6M
Q1 '142014-03-31205.5M
Q4 '132013-12-31348.9M
Q3 '132013-09-30273M
Q2 '132013-06-30262.5M
Q1 '132013-03-31225.5M
Q4 '122012-12-31257.1M
Q3 '122012-09-30269.9M
Q2 '122012-06-30289.3M
Q1 '122012-03-31370.5M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q4 '162016-12-313.1B
Q3 '162016-09-303.1B
Q2 '162016-06-303B
Q1 '162016-03-312.9B
Q4 '152015-12-312.9B
Q3 '152015-09-302.8B
Q2 '152015-06-302.9B
Q1 '152015-03-312.8B
Q4 '142014-12-312.9B
Q3 '142014-09-302.8B
Q2 '142014-06-302.6B
Q1 '142014-03-312.5B
Q4 '132013-12-312.6B
Q3 '132013-09-302.5B
Q2 '132013-06-302.5B
Q1 '132013-03-312.4B
Q4 '122012-12-312.4B
Q3 '122012-09-302.3B
Q2 '122012-06-302.3B
Q1 '122012-03-312.2B

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q4 '162016-12-31843.6M
Q3 '162016-09-30438.9M
Q2 '162016-06-30677.6M
Q1 '162016-03-31179.8M
Q4 '152015-12-31548.3M
Q3 '152015-09-30579.3M
Q2 '152015-06-300
Q1 '152015-03-31832.5M
Q4 '142014-12-31587.6M
Q3 '142014-09-30712.2M
Q2 '142014-06-30449.3M
Q1 '142014-03-31112.3M
Q4 '132013-12-31588.8M
Q3 '132013-09-30605.5M
Q2 '132013-06-30525.1M
Q1 '132013-03-31315.4M
Q4 '122012-12-31571.7M
Q3 '122012-09-30535.4M
Q2 '122012-06-30450.8M
Q1 '122012-03-31481.2M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q4 '162016-12-31561.2M
Q3 '162016-09-30197.3M
Q2 '162016-06-30-78.6M
Q1 '162016-03-31-70.4M
Q4 '152015-12-31242.7M
Q3 '152015-09-30349.7M
Q2 '152015-06-30-835.5M
Q1 '152015-03-31414.7M
Q4 '142014-12-31-990.4M
Q3 '142014-09-30-353.4M
Q2 '142014-06-30229.7M
Q1 '142014-03-31-87.3M
Q4 '132013-12-31353.3M
Q3 '132013-09-30426.6M
Q2 '132013-06-30338.8M
Q1 '132013-03-31168.1M
Q4 '122012-12-31346.3M
Q3 '122012-09-30362.9M
Q2 '122012-06-30297.8M
Q1 '122012-03-31356.8M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q3 '252025-09-30292.1M
Q2 '252025-06-30293.4M
Q1 '252025-03-31293.4M
Q3 '242024-09-30293.4M
Q2 '242024-06-30293.4M
Q1 '242024-03-31293.4M
Q3 '232023-09-30293.4M
Q2 '232023-06-30293.4M
Q1 '232023-03-31293.4M
Q3 '222022-09-30293.4M
Q2 '222022-06-30293.1M
Q1 '222022-03-31293M
Q3 '212021-09-30293M
Q2 '212021-06-30292.9M
Q1 '212021-03-31292.9M
Q3 '202020-09-30292.8M
Q2 '202020-06-30292.7M
Q1 '202020-03-31297.8M
Q3 '192019-09-30301.4M
Q2 '192019-06-30303.5M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q1 '162016-03-313.44
Q4 '152015-12-313.38
Q3 '152015-09-303.44
Q2 '152015-06-303.47
Q1 '152015-03-313.45
Q4 '142014-12-313.44
Q3 '142014-09-303.49
Q2 '142014-06-303.51
Q1 '142014-03-313.60
Q4 '132013-12-313.66
Q3 '132013-09-303.35
Q2 '132013-06-303.32
Q1 '132013-03-313.40
Q4 '122012-12-313.87
Q3 '122012-09-304.04
Q2 '122012-06-304.08
Q1 '122012-03-314.00
Q4 '112011-12-313.52
Q3 '112011-09-303.40
Q2 '112011-06-303.30